Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

EPR-based oximetric imaging: a combination of single point-based spatial encoding and T1 weighting.

Matsumoto KI, Kishimoto S, Devasahayam N, Chandramouli GVR, Ogawa Y, Matsumoto S, Krishna MC, Subramanian S.

Magn Reson Med. 2018 Mar 26. doi: 10.1002/mrm.27182. [Epub ahead of print]

PMID:
29582458
2.

Ornithine decarboxylase as a therapeutic target for endometrial cancer.

Kim HI, Schultz CR, Buras AL, Friedman E, Fedorko A, Seamon L, Chandramouli GVR, Maxwell GL, Bachmann AS, Risinger JI.

PLoS One. 2017 Dec 14;12(12):e0189044. doi: 10.1371/journal.pone.0189044. eCollection 2017.

3.

Design, synthesis and evaluation of novel pyrazolo-pyrimido[4,5-d]pyrimidine derivatives as potent antibacterial and biofilm inhibitors.

Suresh L, Sagar Vijay Kumar P, Poornachandra Y, Ganesh Kumar C, Chandramouli GVP.

Bioorg Med Chem Lett. 2017 Mar 15;27(6):1451-1457. doi: 10.1016/j.bmcl.2017.01.087. Epub 2017 Feb 3.

PMID:
28209374
4.

Accelerated electron paramagnetic resonance imaging using partial Fourier compressed sensing reconstruction.

Chou CC, Chandramouli GV, Shin T, Devasahayam N, McMillan A, Babadi B, Gullapalli R, Krishna MC, Zhuo J.

Magn Reson Imaging. 2017 Apr;37:90-99. doi: 10.1016/j.mri.2016.10.029. Epub 2016 Oct 29.

5.

α-Glucosidase inhibitory activity, molecular docking, QSAR and ADMET properties of novel 2-amino-phenyldiazenyl-4H-chromene derivatives.

Perumal O, Peddakotla SVK, Suresh L, Chandramouli GVP, Pydisetty Y.

J Biomol Struct Dyn. 2017 Sep;35(12):2620-2630. doi: 10.1080/07391102.2016.1227278. Epub 2016 Sep 14. No abstract available.

PMID:
27555333
6.

An efficient one-pot synthesis of thiochromeno[3,4-d]pyrimidines derivatives: Inducing ROS dependent antibacterial and anti-biofilm activities.

Suresh L, Sagar Vijay Kumar P, Poornachandra Y, Ganesh Kumar C, Chandramouli GV.

Bioorg Chem. 2016 Oct;68:159-65. doi: 10.1016/j.bioorg.2016.08.006. Epub 2016 Aug 9.

PMID:
27522461
7.

Ionic liquid-promoted multicomponent synthesis of fused tetrazolo[1,5-a]pyrimidines as α-glucosidase inhibitors.

Suresh L, Onkara P, Kumar PS, Pydisetty Y, Chandramouli GV.

Bioorg Med Chem Lett. 2016 Aug 15;26(16):4007-14. doi: 10.1016/j.bmcl.2016.06.086. Epub 2016 Jun 30.

PMID:
27406797
8.

An expeditious four-component domino protocol for the synthesis of novel thiazolo[3,2-a]thiochromeno[4,3-d]pyrimidine derivatives as antibacterial and antibiofilm agents.

Suresh L, Sagar Vijay Kumar P, Poornachandra Y, Ganesh Kumar C, Babu NJ, Chandramouli GV.

Bioorg Med Chem. 2016 Aug 15;24(16):3808-17. doi: 10.1016/j.bmc.2016.06.025. Epub 2016 Jun 14.

PMID:
27344213
9.

Mass Spectrometry-Based Metabolomics Identifies Longitudinal Urinary Metabolite Profiles Predictive of Radiation-Induced Cancer.

Cook JA, Chandramouli GV, Anver MR, Sowers AL, Thetford A, Krausz KW, Gonzalez FJ, Mitchell JB, Patterson AD.

Cancer Res. 2016 Mar 15;76(6):1569-77. doi: 10.1158/0008-5472.CAN-15-2416. Epub 2016 Feb 15.

10.

Altered expression of microRNA-451 in eutopic endometrium of baboons (Papio anubis) with endometriosis.

Joshi NR, Su RW, Chandramouli GV, Khoo SK, Jeong JW, Young SL, Lessey BA, Fazleabas AT.

Hum Reprod. 2015 Dec;30(12):2881-91. doi: 10.1093/humrep/dev229. Epub 2015 Sep 14.

11.

One-pot three-component domino protocol for the synthesis of novel pyrano[2,3-d]pyrimidines as antimicrobial and anti-biofilm agents.

Suresh L, Poornachandra Y, Kanakaraju S, Ganesh Kumar C, Chandramouli GV.

Org Biomol Chem. 2015 Jul 14;13(26):7294-306. doi: 10.1039/c5ob00693g. Epub 2015 Jun 9.

PMID:
26054925
12.

Design, Synthesis, and In Vitro Antimicrobial Evaluation of Fused Pyrano[3,2-e]tetrazolo[1,5-c]pyrimidines and Diazepines.

Kanakaraju S, Sagar Vijay Kumar P, Prasanna B, Chandramouli GV.

ISRN Org Chem. 2013 Aug 21;2013:635384. doi: 10.1155/2013/635384. eCollection 2013.

13.

Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasion.

Risinger JI, Allard J, Chandran U, Day R, Chandramouli GV, Miller C, Zahn C, Oliver J, Litzi T, Marcus C, Dubil E, Byrd K, Cassablanca Y, Becich M, Berchuck A, Darcy KM, Hamilton CA, Conrads TP, Maxwell GL.

Front Oncol. 2013 Jun 17;3:139. doi: 10.3389/fonc.2013.00139. eCollection 2013.

14.

Gene expression in uterine leiomyoma from tumors likely to be growing (from black women over 35) and tumors likely to be non-growing (from white women over 35).

Davis BJ, Risinger JI, Chandramouli GV, Bushel PR, Baird DD, Peddada SD.

PLoS One. 2013 Jun 13;8(6):e63909. doi: 10.1371/journal.pone.0063909. Print 2013.

15.

Trophoblast lineage cells derived from human induced pluripotent stem cells.

Chen Y, Wang K, Chandramouli GV, Knott JG, Leach R.

Biochem Biophys Res Commun. 2013 Jul 12;436(4):677-84. doi: 10.1016/j.bbrc.2013.06.016. Epub 2013 Jun 15.

16.

Normal viability of Kai1/Cd82 deficient mice.

Risinger JI, Custer M, Feigenbaum L, Simpson RM, Hoover SB, Webster JD, Chandramouli GV, Tessarollo L, Barrett JC.

Mol Carcinog. 2014 Aug;53(8):610-24. doi: 10.1002/mc.22009. Epub 2013 Feb 8.

PMID:
23401136
17.

Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse models.

Birkhäuser FD, Koya RC, Neufeld C, Rampersaud EN, Lu X, Micewicz ED, Chodon T, Atefi M, Kroeger N, Chandramouli GV, Li G, Said JW, McBride WH, Kabbinavar FF, Ribas A, Pantuck AJ, Belldegrun AS, Riss J.

J Immunother. 2013 Feb;36(2):102-11. doi: 10.1097/CJI.0b013e31827bec97.

PMID:
23377663
18.

Dose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1.

Nogueira LM, Lavigne JA, Chandramouli GV, Lui H, Barrett JC, Hursting SD.

Cancer Med. 2012 Oct;1(2):275-88. doi: 10.1002/cam4.23. Epub 2012 Aug 6.

19.

Evaluation of partial k-space strategies to speed up time-domain EPR imaging.

Subramanian S, Chandramouli GV, McMillan A, Gullapalli RP, Devasahayam N, Mitchell JB, Matsumoto S, Krishna MC.

Magn Reson Med. 2013 Sep;70(3):745-53. doi: 10.1002/mrm.24508. Epub 2012 Oct 8.

20.

Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer.

Allard JE, Chandramouli GV, Stagliano K, Hood BL, Litzi T, Shoji Y, Boyd J, Berchuck A, Conrads TP, Maxwell GL, Risinger JI.

Front Oncol. 2012 Jul 4;2:65. doi: 10.3389/fonc.2012.00065. eCollection 2012.

21.

Reporting of quantitative oxygen mapping in EPR imaging.

Subramanian S, Devasahayam N, McMillan A, Matsumoto S, Munasinghe JP, Saito K, Mitchell JB, Chandramouli GV, Krishna MC.

J Magn Reson. 2012 Jan;214(1):244-51. doi: 10.1016/j.jmr.2011.11.013. Epub 2011 Nov 28.

22.

Distinct effects of calorie restriction and exercise on mammary gland gene expression in C57BL/6 mice.

Padovani M, Lavigne JA, Chandramouli GV, Perkins SN, Barrett JC, Hursting SD, Bennett LM, Berrigan D.

Cancer Prev Res (Phila). 2009 Dec;2(12):1076-87. doi: 10.1158/1940-6207.CAPR-09-0034. Epub 2009 Dec 1.

23.

Estimation of tumor microvessel density by MRI using a blood pool contrast agent.

Hyodo F, Chandramouli GV, Matsumoto S, Matsumoto K, Mitchell JB, Krishna MC, Munasinghe JP.

Int J Oncol. 2009 Oct;35(4):797-804.

PMID:
19724915
24.

Identification of new Rel/NFkappaB regulatory networks by focused genome location analysis.

De Siervi A, De Luca P, Moiola C, Gueron G, Tongbai R, Chandramouli GV, Haggerty C, Dzekunova I, Petersen D, Kawasaki E, Kil WJ, Camphausen K, Longo D, Gardner K.

Cell Cycle. 2009 Jul 1;8(13):2093-100. Epub 2009 Jul 5.

25.

Gene expression in human oral squamous cell carcinoma is influenced by risk factor exposure.

Cheong SC, Chandramouli GV, Saleh A, Zain RB, Lau SH, Sivakumaren S, Pathmanathan R, Prime SS, Teo SH, Patel V, Gutkind JS.

Oral Oncol. 2009 Aug;45(8):712-9. doi: 10.1016/j.oraloncology.2008.11.002. Epub 2009 Jan 14.

PMID:
19147396
26.

Concentration-dependent effects of genistein on global gene expression in MCF-7 breast cancer cells: an oligo microarray study.

Lavigne JA, Takahashi Y, Chandramouli GV, Liu H, Perkins SN, Hursting SD, Wang TT.

Breast Cancer Res Treat. 2008 Jul;110(1):85-98. Epub 2007 Aug 9.

PMID:
17687646
27.

Microarray analysis reveals that leptin induces autocrine/paracrine cascades to promote survival and proliferation of colon epithelial cells in an Apc genotype-dependent fashion.

Fenton JI, Lavigne JA, Perkins SN, Liu H, Chandramouli GV, Shih JH, Hord NG, Hursting SD.

Mol Carcinog. 2008 Jan;47(1):9-21.

PMID:
17620308
28.

Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation.

Tsai MH, Cook JA, Chandramouli GV, DeGraff W, Yan H, Zhao S, Coleman CN, Mitchell JB, Chuang EY.

Cancer Res. 2007 Apr 15;67(8):3845-52.

29.

Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma.

Dainty LA, Risinger JI, Morrison C, Chandramouli GV, Bidus MA, Zahn C, Rose GS, Fowler J, Berchuck A, Maxwell GL.

Gynecol Oncol. 2007 Jun;105(3):563-70. Epub 2007 Apr 2.

PMID:
17400285
30.

Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression.

Risinger JI, Chandramouli GV, Maxwell GL, Custer M, Pack S, Loukinov D, Aprelikova O, Litzi T, Schrump DS, Murphy SK, Berchuck A, Lobanenkov V, Barrett JC.

Clin Cancer Res. 2007 Mar 15;13(6):1713-9.

31.
32.

2-methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: molecular distinctions from the mammary gland of pregnant mice.

Huh JI, Qiu TH, Chandramouli GV, Charles R, Wiench M, Hager GL, Catena R, Calvo A, LaVallee TM, Desprez PY, Green JE.

Endocrinology. 2007 Mar;148(3):1266-77. Epub 2006 Dec 7.

PMID:
17158205
33.

Selective leukemic-cell killing by a novel functional class of thalidomide analogs.

Ge Y, Montano I, Rustici G, Freebern WJ, Haggerty CM, Cui W, Ponciano-Jackson D, Chandramouli GV, Gardner ER, Figg WD, Abu-Asab M, Tsokos M, Jackson SH, Gardner K.

Blood. 2006 Dec 15;108(13):4126-35. Epub 2006 Aug 29.

34.

Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray.

Takahashi Y, Lavigne JA, Hursting SD, Chandramouli GV, Perkins SN, Kim YS, Wang TT.

Mol Carcinog. 2006 Dec;45(12):943-56.

PMID:
16865672
35.

Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma.

Riss J, Khanna C, Koo S, Chandramouli GV, Yang HH, Hu Y, Kleiner DE, Rosenwald A, Schaefer CF, Ben-Sasson SA, Yang L, Powell J, Kane DW, Star RA, Aprelikova O, Bauer K, Vasselli JR, Maranchie JK, Kohn KW, Buetow KH, Linehan WM, Weinstein JN, Lee MP, Klausner RD, Barrett JC.

Cancer Res. 2006 Jul 15;66(14):7216-24.

36.

Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection.

Aprelikova O, Wood M, Tackett S, Chandramouli GV, Barrett JC.

Cancer Res. 2006 Jun 1;66(11):5641-7.

37.

Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray.

Bidus MA, Risinger JI, Chandramouli GV, Dainty LA, Litzi TJ, Berchuck A, Barrett JC, Maxwell GL.

Clin Cancer Res. 2006 Jan 1;12(1):83-8.

38.

Transcriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cells.

Tsai MH, Chen X, Chandramouli GV, Chen Y, Yan H, Zhao S, Keng P, Liber HL, Coleman CN, Mitchell JB, Chuang EY.

Oncogene. 2006 Jan 26;25(4):622-32.

PMID:
16247478
39.

Molecular alterations in primary prostate cancer after androgen ablation therapy.

Best CJ, Gillespie JW, Yi Y, Chandramouli GV, Perlmutter MA, Gathright Y, Erickson HS, Georgevich L, Tangrea MA, Duray PH, González S, Velasco A, Linehan WM, Matusik RJ, Price DK, Figg WD, Emmert-Buck MR, Chuaqui RF.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6823-34.

40.

Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.

Zorn KK, Bonome T, Gangi L, Chandramouli GV, Awtrey CS, Gardner GJ, Barrett JC, Boyd J, Birrer MJ.

Clin Cancer Res. 2005 Sep 15;11(18):6422-30.

41.

Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers.

Jazaeri AA, Awtrey CS, Chandramouli GV, Chuang YE, Khan J, Sotiriou C, Aprelikova O, Yee CJ, Zorn KK, Birrer MJ, Barrett JC, Boyd J.

Clin Cancer Res. 2005 Sep 1;11(17):6300-10.

42.

Pharmacologic profiling of transcriptional targets deciphers promoter logic.

Freebern WJ, Haggerty CM, Montano I, McNutt MC, Collins I, Graham A, Chandramouli GV, Stewart DH, Biebuyck HA, Taub DD, Gardner K.

Pharmacogenomics J. 2005;5(5):305-23.

PMID:
16044165
43.

Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling.

Risinger JI, Maxwell GL, Chandramouli GV, Aprelikova O, Litzi T, Umar A, Berchuck A, Barrett JC.

Cancer Res. 2005 Jun 15;65(12):5031-7.

44.

Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.

Maxwell GL, Chandramouli GV, Dainty L, Litzi TJ, Berchuck A, Barrett JC, Risinger JI.

Clin Cancer Res. 2005 Jun 1;11(11):4056-66.

45.

Three microarray platforms: an analysis of their concordance in profiling gene expression.

Petersen D, Chandramouli GV, Geoghegan J, Hilburn J, Paarlberg J, Kim CH, Munroe D, Gangi L, Han J, Puri R, Staudt L, Weinstein J, Barrett JC, Green J, Kawasaki ES.

BMC Genomics. 2005 May 5;6:63.

46.

Evaluation of hybridization conditions for spotted oligonucleotide-based DNA microarrays.

Tsai MH, Yan H, Chen X, Chandramouli GV, Zhao S, Coffin D, Coleman CN, Mitchell JB, Chuang EY.

Mol Biotechnol. 2005 Mar;29(3):221-4.

PMID:
15767699
47.

An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.

Furumoto H, Ying H, Chandramouli GV, Zhao L, Walker RL, Meltzer PS, Willingham MC, Cheng SY.

Mol Cell Biol. 2005 Jan;25(1):124-35.

48.

BRCA1, histone H2AX phosphorylation, and male meiotic sex chromosome inactivation.

Turner JM, Aprelikova O, Xu X, Wang R, Kim S, Chandramouli GV, Barrett JC, Burgoyne PS, Deng CX.

Curr Biol. 2004 Dec 14;14(23):2135-42.

49.

The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidine.

Alleman WG, Tabios RL, Chandramouli GV, Aprelikova ON, Torres-Cabala C, Mendoza A, Rogers C, Sopko NA, Linehan WM, Vasselli JR.

Clin Cancer Res. 2004 Oct 15;10(20):7011-21. Erratum in: Clin Cancer Res. 2005 Feb 15;11(4):1684. Rodgers, Craig [corrected to Rogers, Craig].

50.

BRCA1-mediated repression of select X chromosome genes.

Jazaeri AA, Chandramouli GV, Aprelikova O, Nuber UA, Sotiriou C, Liu ET, Ropers HH, Yee CJ, Boyd J, Barrett JC.

J Transl Med. 2004 Sep 21;2(1):32.

Supplemental Content

Loading ...
Support Center